Rare neurology is entering a pivotal moment. Scientific understanding is accelerating, new technologies are maturing, and the patient need remains profoundly unmet. As the biopharmaceutical community ...
In its second AI-focused deal in the space of a week, Servier has announced a partnership with Iktos aimed at finding new, small-molecule therapies for a range of diseases, including cancer and ...
Right on the heels of its IPO, Insilico Medicine is starting the year with an oncology discovery and development pact with French pharma Servier. The artificial intelligence biotech could nab up to ...
Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug ...
« L’Europe ne peut pas être la seule zone économique à maintenir un marché ouvert à une concurrence qui détruit son industrie » Dans l’industrie, la compétition avec la Chine constitue la menace la ...
PARIS, FRANCE, January 8, 2026 /EINPresswire.com/ — Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, today announced a ...
Insilico Medicine has entered a multi-year research and development (R&D) collaboration with Servier, worth up to $888m, to develop and discover new oncology therapies. The partnership combines ...
The Musée régional d’art contemporain Occitanie (Mrac) is inviting visitors on a dynamic journey through its collections with a new exhibition titled "ALLONS." Galerie Nathalie Obadia is presenting ...
Adepte des jeux de lettres, testez vos connaissances et votre culture générale avec nos mots fléchés force 4, les plus difficiles de tous ! Chaque jour, Le Parisien publie une nouvelle grille de mots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results